 |
|
Aspirin treatment failure warning
August 10, 2005Treatment failures occur with any drug and aspirin is no exception. Evidence is growing that some people will not respond to the anti-coagulant action of aspirin and the drug will not protect against cardiovascular events despite its regular intake.
Professor Andrew Szczeklik from Poland and Professor Graeme Hankey from Western Australia will present the latest findings on aspirin resistance at the XXth Congress of the International Society of Thrombosis and Haemostasis today.
"There are at least two possible explanations for the aspirin-resistance phenomenon," said Professor Szczeklik. "One is high levels of blood cholesterol, which can in itself promote coagulation events in the blood stream. In patients with high cholesterol levels, aspirin in in normal doses has hardly any anti-clotting effects, whereas treatment with a statin (inhibitor of cholesterol) significantly reduces blood clotting. In patients with coronary heart disease, aspirin exerts it anti-coagulant effects only when blood cholesterol is in the 'normal' range."
Szczeklik went onto say, "A patients genetic make-up may alter their response to aspirin resistance.. For example, in coronary heart disease patients carrying one particular gene are resistant to the anti-coagulant action of aspirin and are at increased risk of an acute coronary event."
Perth researcher, Professor Graeme Hankey, has shown that patients who show evidence of aspirin resistance do respond well to another drug called Clopidogrel.
"Clopidogrel had anti-clotting and anti-inflammatory effects in patients with diseased arteries. These effects were greatest in the aspirin-resistant patients," said Hankey.
"The use of aspirin has risen dramatically in Australia in the late 1990's. This is why it is vital that aspirin resistance is considered when implementing anti-clotting therapy. Present data indicate that this particularly applies to survivors of a heart attack or unstable angina, patients receiving bypass surgery as well as people with high cholesterol," reported Hankey.
Research Australia
Szczeklik went onto say, "A patients genetic make-up may alter their response to aspirin resistance.. For example, in coronary heart disease patients carrying one particular gene are resistant to the anti-coagulant action of aspirin and are at increased risk of an acute coronary event."
Perth researcher, Professor Graeme Hankey, has shown that patients who show evidence of aspirin resistance do respond well to another drug called Clopidogrel.
"Clopidogrel had anti-clotting and anti-inflammatory effects in patients with diseased arteries. These effects were greatest in the aspirin-resistant patients," said Hankey.
"The use of aspirin has risen dramatically in Australia in the late 1990's. This is why it is vital that aspirin resistance is considered when implementing anti-clotting therapy. Present data indicate that this particularly applies to survivors of a heart attack or unstable angina, patients receiving bypass surgery as well as people with high cholesterol," reported Hankey.
Research Australia
Aspirin Current Events and Aspirin News RSSNovel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system.
Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes
Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA.
Quintet of proteins forms new, early-warning blood test before heart attack strikes
A team of Johns Hopkins biochemists has identified a mixed bag of five key proteins out of thousands secreted into blood draining from the heart's blood vessels that may together or in certain quantities form the basis of a far more accurate early warning test than currently in use of impending heart attack in people with severely reduced blood flow, or ischemia.
Hospital rankings: More than meets the eye
Medicare's pay-for-performance program ranks and rewards hospitals according to how well they meet certain guidelines for clinical care.
Aspirin does not prevent heart attacks in patients with diabetes
Taking regular aspirin and antioxidant supplements does not prevent heart attacks even in high risk groups with diabetes and asymptomatic arterial disease, and aspirin should only be given to patients with established heart disease, stroke or limb arterial disease.
Triple antiplatelet therapy appears superior to dual antiplatelet therapy
Results of five research studies and a clinical registry first-report presentation scheduled for the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents achieves greater platelet inhibition than conventional dual antiplatelet therapy.
New devices used to reduce arterial occlusions, provide cardiac support, highlighted at TCT 2008
Research results highlighting three new devices used to reduce blockages in peripheral and coronary arteries and to provide cardiac support will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
Aspirin and atherosclerosis
Aspirin has become one of the most widely used medications in the world, owing to its ability to reduce pain, fevers, inflammation, and blood clotting.
Unusual case of a woman who suffered stroke during sex
Minutes after having sexual intercourse with her boyfriend, a 35-year-old woman suddenly felt her left arm go weak. Her speech became slurred and she lost feeling on the left side of her face.
Common painkillers lower levels of prostate cancer biomarker
Common painkillers like aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer.
More Aspirin Current Events and Aspirin News Articles
 | How Does Aspirin Find a Headache? (Imponderables Books) by David Feldman Ponder, if you will ... Do snakes sneeze? Why didn't the three musketeers carry muskets? What happens to the holes that are punched out of looseleaf paper? Why don't people smile in old photos? Pop culture guru David Feldman demystifies these questions and much more in How Does Aspirin Find a Headache? Part of the Imponderables® series -- the unchallenged source of answers to civilization's most... |
 | Aspirin: The Remarkable Story of a Wonder Drug by Diarmuid Jeffreys Diarmuid Jeffreys traces the story of aspirin from the drug’s origins in ancient Egypt, through its industrial development at the end of the nineteenth century and its key role in the great flu pandemic of 1918, to its subsequent exploitation by the pharmaceutical conglomerates and the marvelous powers still being discovered today.... |
 | The Aspirin Alternative: The Natural Way to Overcome Chronic Pain by Loes Michael Provides information about the all-natural anti-inflammatory medicine that is the leading non-aspirin drug in Germany... |
 | Beyond Aspirin : Nature's Challenge to Arthritis, Cancer & Alzheimer's Disease by Thomas M. Newmark, Paul Schulick Covers: How the COX-2 enzyme creates inflammation in the body; The relationship between COX-2 inflammation and arthritis, specific cancers, and Alzheimer's disease; Herbs and dietary strategies proven to inhibit COX-2 inflammation safely; The dangers of the pharmaceutical 'silver bullet' approach to COX-2 inhibition; Comprehensive scientific support for the herbal strategy; Practical guidelines... |
 | Aspirin and Related Drugs Reviewing over a century of aspirin research and use, Aspirin and Related Drugs provides a comprehensive source of information on the history, chemistry, absorption in the body, therapeutic effects, toxicology, elimination, and future uses of aspirin. Highlighting the historical evolution of the salicylates and the commercial development of aspirin, the book reviews the pharmacokinetics of the... |
 | Noni: Aspirin of the Ancients by Diana Fairechild |
| Aspirin Volume 2 (Aspirin) by Eun-jeong Kim | |
| The Aspirin Wars: Money, Medicine and 100 Years of Rampant Competition by Charles C. Mann, Mark L. Plummer Mann and Plummer take us behind the scenes in the aspirin wars to penetrate the shores of capitalism and show the essence of competition at its canniest, most ruthless, most brilliant, and most fierce.ights to Atlantic. 8 pages of... | |
 | A Cuppa Tea and an Aspirin by Helen Forrester |
 | Aspirin Volume 1 (Aspirin) by Eun-jeong Kim |
| © 2008 BrightSurf.com |